MarketCapTrends
CRL

Charles River Laboratories International, Inc. (CRL)

NYSE · Healthcare

Charles River Laboratories International, Inc. annual/quarterly total liabilities history from 2009 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.

  • Charles River Laboratories International, Inc. total liabilities for the quarter ending December 27, 2025 were 3.92B, a 2.39% decrease year-over-year.
  • Charles River Laboratories International, Inc. total liabilities for 2025 were 3.92B, a 2.39% decrease from 2024.
  • Charles River Laboratories International, Inc. total liabilities for 2024 were 4.02B, a 11.37% decrease from 2023.
  • Charles River Laboratories International, Inc. total liabilities for 2023 were 4.54B, a 0.94% decrease from 2022.
  • Charles River Laboratories International, Inc. total liabilities for 2022 were 4.58B.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
Charles River Laboratories International, Inc. Annual Total Liabilities (Millions of US $)
2025$3,924
2024$4,020
2023$4,536
2022$4,579
2021$4,432
2020$3,347
2019$3,026
2018$2,518
2017$1,866
2016$1,858
2015$1,303
2014$1,166
2013$968
2012$983
2011$1,031
Charles River Laboratories International, Inc. Quarterly Total Liabilities (Millions of US $)
2025-12-27$3,924
2024-12-28$4,020
2023-12-30$4,536
2022-12-31$4,579
2021-12-25$4,432
2020-12-26$3,347
2019-12-28$3,026
2018-12-29$2,518
2017-12-30$1,866
2016-12-31$1,858
2015-12-26$1,303
2014-12-27$1,166
2013-12-28$968
2012-12-29$983
2011-12-31$1,031
2010-12-25$1,045
2009-12-26$830

Charles River Laboratories International, Inc. Total Liabilities — FAQ

Charles River Laboratories International, Inc. (CRL) total liabilities over the last 18 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see CRL's total liabilities history?

The chart and table above show Charles River Laboratories International, Inc.'s total liabilities by year and by quarter, including the growth rate.